Journal article
Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease
Abstract
BACKGROUND AND PURPOSE: In Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcomes (AIM-HIGH) trial, addition of extended-release niacin (ERN) to simvastatin in participants with established cardiovascular disease, low high-density lipoprotein cholesterol, and high triglycerides had no incremental benefit, despite increases in high-density lipoprotein cholesterol. Preliminary …
Authors
Teo KK; Goldstein LB; Chaitman BR; Grant S; Weintraub WS; Anderson DC; Sila CA; Cruz-Flores S; Padley RJ; Kostuk WJ
Journal
Stroke, Vol. 44, No. 10, pp. 2688–2693
Publisher
Wolters Kluwer
Publication Date
October 2013
DOI
10.1161/strokeaha.113.001529
ISSN
0039-2499